Physician

Amir Kaykha, M.D.

According to 2025 Medicare claims, Amir Kaykha, M.D. (NPI: 1639375959) practices interventional cardiology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is AMIR KAYKHA MD INC (NPI: 1881973626; TIN: 452860422) and primary practice location at 95124-4003.

Kaykha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 572 traditional Medicare patients, billed 6,705 HCPCS/CPT codes, and received $1,168,178 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,991 prescription claims across 501 beneficiaries totaling $1,370,493 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 14 claims. Open Payments data shows 7 records totaling $456. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $166,127 to $1,168,178. Similarly, Part D prescription costs have moved sharply higher in recent years, from $84,861 to $1,370,493. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	275	1,641	$166,127
2016	337	2,171	$290,483
2017	380	2,398	$313,820
2018	503	11,932	$592,075
2019	525	17,369	$839,511
2020	600	17,150	$1,151,934
2021	631	18,591	$1,261,022
2022	577	16,780	$1,137,093
2023	581	12,395	$965,324
2024	572	6,705	$1,168,178

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	109	1,028	$84,861
2016	113	1,153	$108,582
2017	147	1,547	$170,388
2018	246	2,106	$235,679
2019	328	3,194	$498,876
2020	446	3,752	$720,712
2021	535	5,308	$1,196,782
2022	524	5,453	$1,423,066
2023	513	5,250	$1,499,582
2024	501	4,991	$1,370,493

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$25,100
2017	N/R	15	$30,627
2018	N/R	14	$29,443
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	400	426	$171
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	452	965	$124
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	241	243	$79
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	475	1,088	$14
J7050	Infusion, normal saline solution, 250 cc	241	243	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	329	23,490	$453,697
Xarelto	Rivaroxaban	144	10,530	$194,691
Entresto	Sacubitril/Valsartan	129	8,768	$156,153
Repatha Sureclick	Evolocumab	87	5,068	$84,039
Farxiga	Dapagliflozin Propanediol	64	4,770	$83,957

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$456	ShockWave Medical, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amir Kaykha, M.D.?

Tedicare shows public-source Medicare data for Amir Kaykha, M.D. (NPI 1639375959), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amir Kaykha, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amir Kaykha, M.D.?

Amir Kaykha, M.D. is linked to AMIR KAYKHA MD INC (billing NPI 1881973626) in the available physician profile data.

Does Amir Kaykha, M.D. have Open Payments data?

Amir Kaykha, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.